Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on E Cigarette Ingredients. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115786418A reveals immobilized enzyme method for (S)-nornicotine. Offers high purity, reusability, and cost reduction for e-cigarette and pharma supply chains.
Patent CN111233829A details a mild asymmetric reduction method for high-purity nicotine, offering significant cost reduction in fine chemical manufacturing and scalable supply chain solutions.
Novel asymmetric synthesis of S-nicotine via tert-butyl sulfinamide induction. Offers high ee value, mild conditions, and scalable production for e-cigarette manufacturers.
Patent CN113387925B reveals a cost-effective S-nicotine synthesis using glutarate. Discover high-purity manufacturing solutions and supply chain advantages.
Patent CN114644614B details a novel 3-step synthesis for L-nicotine achieving >99.9% optical purity. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN115286615A details a mild, high-yield synthesis of racemic nicotine avoiding cryogenic conditions, offering significant cost reduction and supply chain stability for electronic cigarette and pharmaceutical manufacturers.
Patent CN115286615A details a mild, high-yield synthetic route for racemic nicotine using 3-pyridine acetonitrile, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.